LRMR
LRMR
NASDAQ · Biotechnology

Larimar Therapeutics Inc

$2.70
-0.03 (-1.10%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +761.9% upside
Low Target $16.60
Average Target $23.27
High Target $30.48
Current Price $2.70
Current
$2.70
Target
$23.27
$16.60 $23.27 avg $30.48
Scenario Analysis
Bear Case
$16.60
514.8%
Low target
Base Case
$23.27
+761.9%
Avg target
Bull Case
$30.48
+1,028.9%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.42
-57.9% from high
52-Week Low
$1.92
+41.0% from low
Target vs 52W High
$23.27
+262.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%